Clincosm LogoSign in Get a demo

Dyslipidemias

Showing 51 - 75 of 300
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Different Equations to Accurately Calculate LDL Cholesterol

Active, not recruiting
  • Dyslipidemias
  • Lipid Disorder
  • no intervention, Serum LDL cholesterol calculation
  • Bron, France
    Laboratoire de Biologie Médicale Multi Sites, Centre de Biologie
Oct 24, 2022

Hypercholesterolemia, Cardiovascular Risk Factor, Dyslipidemias Trial in Clermont-Ferrand (TOTUM-070)

Recruiting
  • Hypercholesterolemia
  • +4 more
  • TOTUM-070
  • Clermont-Ferrand, France
    CIC Clermont Ferrand
Oct 25, 2022

STEMI, Dyslipidemias Trial (Evolocumab)

Not yet recruiting
  • STEMI
  • Dyslipidemias
  • (no location specified)
Oct 12, 2022

PreDiabetes, Obesity, Dyslipidemias Trial in Thessaloniki (Crocus Kozanis, Placebo of Crocus Kozanis, Metformin)

Recruiting
  • PreDiabetes
  • +2 more
  • Crocus Kozanis
  • +2 more
  • Thessaloniki, Greece
    Unit of Paediatric Endocrinology and Metabolism, 2nd Department
Oct 11, 2022

Dyslipidemias, Hypertension Trial in Daegu (Rosuampin 10/5mg, Rosuampin 20/5mg, Amlodipine/Atorvastatin 5/20mg)

Completed
  • Dyslipidemias
  • Hypertension
  • Rosuampin 10/5mg
  • +2 more
  • Daegu, Korea, Republic of
    Daegu Catholic Univ. Medical Center
Oct 10, 2022

Dyslipidemias, Atherosclerosis, Diabetes, Type 2 Trial (Omega 3-Atorvastatin, Atorvastatin-Ezetimibe)

Recruiting
  • Dyslipidemias
  • +2 more
  • Seongnam, Gyeonggi, Korea, Republic of
    SNUBH
Oct 1, 2022

Dyslipidemia in Patients at High Risk and Very High Risk of

Recruiting
  • Secondary Prevention
  • +2 more
  • application
  • Leon, Guanajuato, Mexico
    Umae Cmn T1
Sep 13, 2022

Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder Trial in Moscow (Pitavastatin, PCSK9 inhibitor)

Recruiting
  • Dyslipidemias
  • +5 more
  • Moscow, Russian Federation
    National Medical Research Centre for Therapy and Preventive Medi
Sep 8, 2022

Coronary Artery Disease, Coronary Heart Disease, Hypertension Trial in Philadelphia (Gamification Intervention)

Not yet recruiting
  • Coronary Artery Disease
  • +6 more
  • Gamification Intervention
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 3, 2022

Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases Trial in Worldwide (LY3561774, Placebo)

Recruiting
  • Dyslipidemias
  • +3 more
  • Waterbury, Connecticut
  • +40 more
Aug 17, 2022

Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Placebo)

Recruiting
  • Dyslipidemias
  • +8 more
  • Sarasota, Florida
  • +11 more
Aug 10, 2022

Dyslipidemias Trial in United States (LY3561774, Placebo)

Completed
  • Dyslipidemias
  • Cypress, California
  • +4 more
Aug 9, 2022

Dyslipidemias Trial in Japan (K-877 ER 0.2 mg/day morning administration (once daily), K-877 ER 0.2 mg/day evening

Completed
  • Dyslipidemias
  • K-877 ER 0.2 mg/day morning administration (once daily)
  • K-877 ER 0.2 mg/day evening administration (once daily)
  • Fukuoka, Japan
  • +13 more
Aug 8, 2022

Cardiovascular Diseases, Dyslipidemias Trial in Yinchuan (Walnuts 30 grams, Walnuts 60 grams)

Completed
  • Cardiovascular Diseases
  • Dyslipidemias
  • Walnuts 30 grams
  • Walnuts 60 grams
  • Yinchuan, Ningxia, China
    Yi Zhao
Aug 8, 2022

Dyslipidemias, Cardiovascular Diseases, HIV Trial in San Francisco (Bempedoic acid, Placebo)

Not yet recruiting
  • Dyslipidemias
  • +3 more
  • Bempedoic acid
  • Placebo
  • San Francisco, California
    San Francisco General Hospital
Aug 3, 2022

Hypercholesterolemia, Familial, Dyslipidemias, Cardiovascular Diseases Trial in Rostock, Dresden (Lipoprotein Apheresis MONET

Completed
  • Hypercholesterolemia, Familial
  • +2 more
  • Lipoprotein Apheresis MONET and DALI
  • Lipoprotein Apheresis DIAMED and DALI
  • Rostock, Mecklenburg-Vorpommern, Germany
  • +1 more
Jul 27, 2022

Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Ezetimibe 10mg, Obicetrapib )

Active, not recruiting
  • Dyslipidemias
  • +2 more
  • Gardena, California
  • +6 more
Jul 14, 2022

Coronary Artery Disease, Bypass Graft Stenosis, Dyslipidemias Trial (Computed tomography coronary angiogram)

Not yet recruiting
  • Coronary Artery Disease
  • +7 more
  • Computed tomography coronary angiogram
  • (no location specified)
May 24, 2022

Impact of a Regional Program Agir Sur Sa SantE

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +5 more
  • Implementation of a new regional care framework
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
May 17, 2022

Metabolic Syndrome X, Overweight, Hypertension Trial in Saint Louis (Placebo Comparator: First Intervention (3 weeks), Active

Completed
Has Results
  • Metabolic Syndrome X
  • +4 more
  • Placebo Comparator: First Intervention (3 weeks)
  • +3 more
  • Saint Louis, Missouri
    Washington University in St. Louis
Apr 13, 2022

Antihypertensive Drugs and Statins by Hair Analysis

Not yet recruiting
  • Arterial Hypertension
  • +4 more
  • Hair analysis for drug concentration
  • Verona, Italy
    Azienda Ospedaliera Universitaria Integrata Verona
Apr 26, 2022

Cardiovascular Diseases, Diabetes, Hypertension Trial in Athens (The Complete Health Improvement Program)

Recruiting
  • Cardiovascular Diseases
  • +4 more
  • The Complete Health Improvement Program
  • Athens, Ohio
    Ohio University
Apr 18, 2022

Laparoscopic-Roux-en-Y Gastric Bypass, Obesity, Diabetes, Type 2 Trial in Denia, Mataró, Fuenlabrada (Roux-en-Y Gastric Bypass

Active, not recruiting
  • Laparoscopic-Roux-en-Y Gastric Bypass
  • +5 more
  • Roux-en-Y Gastric Bypass (RYGB) measuring the lengh of the common limb
  • Denia, Alicante, Spain
  • +2 more
Apr 18, 2022

Dyslipidemias Trial in Bhubaneshwar (drug, dietary supplement, other)

Completed
  • Dyslipidemias
  • Atorvastatin 10mg
  • +2 more
  • Bhubaneshwar, Odisha, India
    AIIMS, Bhubaneswar
Apr 5, 2022

Lipid Profile and Diabetes Mellitus in People With HIV

Recruiting
  • HIV Infections
  • +3 more
    • Vienna, Austria
      Schalk:Pichler Gruppenpraxis
    Apr 4, 2022